Your browser doesn't support javascript.
loading
Gender diversity in adolescents with polycystic ovary syndrome.
Schweisberger, Cintya L; Hornberger, Laurie; Barral, Romina; Burke, Charles; Paprocki, Emily; Sherman, Ashley; Vanden Brink, Heidi; Burgert, Tania S.
Afiliação
  • Schweisberger CL; Division of Endocrinology, Children's Mercy Hospital, Kansas City, MO, USA.
  • Hornberger L; Division of Adolescent Medicine, Children's Mercy Hospital, Kansas City, MO, USA.
  • Barral R; Division of Adolescent Medicine, Children's Mercy Hospital, Kansas City, MO, USA.
  • Burke C; University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
  • Paprocki E; University of Kansas Medical Center, Kansas City, KS, USA.
  • Sherman A; Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
  • Vanden Brink H; Division of Endocrinology, Children's Mercy Hospital, Kansas City, MO, USA.
  • Burgert TS; University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
J Pediatr Endocrinol Metab ; 35(11): 1422-1428, 2022 Nov 25.
Article em En | MEDLINE | ID: mdl-36198004
ABSTRACT

OBJECTIVES:

The objective of our study was to describe the prevalence of gender diverse (GD) youth  among adolescents with polycystic ovary syndrome (PCOS).

METHODS:

We conducted a retrospective chart review on patients who met NIH criteria for PCOS in our Multidisciplinary Adolescent PCOS Program (MAPP). We compared those with PCOS to MAPP patients who did not meet PCOS criteria as well as to non-PCOS patients from the Adolescent Specialty Clinic (ASC). Variables analyzed included gender identity, androgen levels, hirsutism scores, and mood disorders. We used chi-square, Fisher's exact, t-tests, and Wilcoxon rank sum tests to compare groups.  Gender identities self-reported as male, fluid/both or nonbinary  were pooled into the GD category.

RESULTS:

Within the MAPP, 7.6% (n=12) of PCOS youth self-identified as GD compared to 1.8% (n=3) of non PCOS youth (p=0.01, chi-square). When compared to non-PCOS GD adolescents from ASC (4.4%; n=3), the difference to PCOS youth was no longer significant (p=0.56). Among MAPP patients, gender diversity was associated with higher hirsutism scores (p<0.01), but not higher androgen levels. In PCOS, depression/anxiety was higher in GD vs cisgender youth (100% vs. 37.6%, p<0.01 and 77.8% vs. 35.8%, p=0.03 respectively).

CONCLUSIONS:

Gender diversity was observed more commonly in those meeting PCOS criteria. PCOS GD youth were more hirsute and reported more depression/anxiety. Routine screening for differences in gender identity in comprehensive adolescent PCOS programs could benefit these patients, as alternate treatment approaches may be desired to support a transmasculine identity.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do Ovário Policístico Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do Ovário Policístico Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article